Avanos Medical, Inc. is a medical technology company that provides medical device solutions across various global markets, including North America, Europe, and Asia Pacific. Its primary revenue streams come from chronic care products (approximately 50%), which include digestive health and respiratory health devices, and non-opioid pain solutions (approximately 50%), which encompass acute pain products and interventional pain therapies. The company sells its products directly to healthcare providers and facilities, as well as through third-party distributors. Factors supporting its endurance include the growing demand for innovative medical solutions and a focus on non-opioid pain management. However, competition in the medical device industry and regulatory challenges could limit its growth potential.
—
Avanos Medical, Inc. is a medical technology company that provides medical device solutions across various global markets, including North America, Europe, and Asia Pacific. Its primary revenue streams come from chronic care products (approximately 50%), which include digestive health and respiratory health devices, and non-opioid pain solutions (approximately 50%), which encompass acute pain products and interventional pain therapies. The company sells its products directly to healthcare providers and facilities, as well as through third-party distributors. Factors supporting its endurance include the growing demand for innovative medical solutions and a focus on non-opioid pain management. However, competition in the medical device industry and regulatory challenges could limit its growth potential.
—
Daily adjusted close
Avanos Medical, Inc. is a medical technology company that provides medical device solutions across various global markets, including North America, Europe, and Asia Pacific. Its primary revenue streams come from chronic care products (approximately 50%), which include digestive health and respiratory health devices, and non-opioid pain solutions (approximately 50%), which encompass acute pain products and interventional pain therapies. The company sells its products directly to healthcare providers and facilities, as well as through third-party distributors. Factors supporting its endurance include the growing demand for innovative medical solutions and a focus on non-opioid pain management. However, competition in the medical device industry and regulatory challenges could limit its growth potential.